Although weight-loss surgery has been shown to be an effective long-term health treatment, it is not without its drawbacks.
These include its high cost, the possibility of unpleasant side effects, its invasive nature, and the fact that about a third of patients will need additional surgery.
So, it should come as no surprise that only approximately 1% of those with legitimate weight-related problems really take the plunge.
The management of bile acid levels and hunger is emphasized as one of the metabolic advantages of weight reduction surgery in a recent research.
Scientists have developed a novel chimeric antigen receptor (CAR) T-cell via genetic engineering.
This provides hope for the development of a non-surgical therapy to aid in weight loss by emulating these effects on hunger and metabolism.
This is not the first time scientists have looked to the gut microbiome for weight-loss answers.
A safe and effective therapy for obesity might be developed by investigating the metabolic pathways that result in reduced hunger.
The severity of many illnesses, such as diabetes and heart disease, that are linked to obesity may be improved or even reversed by losing weight.
LIKE SAVE SHARE....